Summary: A Japanese research team is developing a tooth regrowth medicine, with clinical trials set to begin in July 2024. The medicine is intended for people lacking a full set of adult teeth due to congenital factors, and the team aims to have it ready for general use by 2030. In animal experiments, the medicine prompted the growth of "third-generation" teeth after baby and permanent adult teeth.